These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH; Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333 [TBL] [Abstract][Full Text] [Related]
4. An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation. Hohnloser SH; Connolly SJ; John Camm A; Halperin JL; Radzik D Europace; 2014 Aug; 16(8):1117-24. PubMed ID: 24728270 [TBL] [Abstract][Full Text] [Related]
5. Increased mortality after dronedarone therapy for severe heart failure. Køber L; Torp-Pedersen C; McMurray JJ; Gøtzsche O; Lévy S; Crijns H; Amlie J; Carlsen J; N Engl J Med; 2008 Jun; 358(25):2678-87. PubMed ID: 18565860 [TBL] [Abstract][Full Text] [Related]
6. Dronedarone-induced digoxin toxicity: new drug, new interactions. Vallakati A; Chandra PA; Pednekar M; Frankel R; Shani J Am J Ther; 2013; 20(6):e717-9. PubMed ID: 21519214 [TBL] [Abstract][Full Text] [Related]
7. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH; Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319 [TBL] [Abstract][Full Text] [Related]
8. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial. Salam AM Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1345-9. PubMed ID: 23244355 [TBL] [Abstract][Full Text] [Related]
9. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH; N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843 [TBL] [Abstract][Full Text] [Related]
10. Effect of dronedarone on cardiovascular events in atrial fibrillation. Hohnloser SH; Crijns HJ; van Eickels M; Gaudin C; Page RL; Torp-Pedersen C; Connolly SJ; N Engl J Med; 2009 Feb; 360(7):668-78. PubMed ID: 19213680 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland. Åkerborg Ö; Nilsson J; Bascle S; Lindgren P; Reynolds M Clin Ther; 2012 Aug; 34(8):1788-802. PubMed ID: 22770643 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure. Chatterjee S; Ghosh J; Lichstein E; Aikat S; Mukherjee D Am J Cardiol; 2012 Aug; 110(4):607-13. PubMed ID: 22608952 [TBL] [Abstract][Full Text] [Related]
13. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects. Prescrire Int; 2010 Aug; 19(108):149-52. PubMed ID: 20939439 [TBL] [Abstract][Full Text] [Related]
14. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of dronedarone: a review of randomized trials. Christiansen CB; Torp-Pedersen C; Køber L Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756 [TBL] [Abstract][Full Text] [Related]
16. Amiodarone and dronedarone: An update. Vamos M; Hohnloser SH Trends Cardiovasc Med; 2016 Oct; 26(7):597-602. PubMed ID: 27155812 [TBL] [Abstract][Full Text] [Related]
17. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. Reynolds MR; Lin J; Jhaveri M; Mozaffari E; Plich A Am J Ther; 2014; 21(6):500-8. PubMed ID: 23344106 [TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers. Ezekowitz MD; Ellenbogen KA; DiMarco JP; Kaszala K; Boddy A; Geba GP; Koren A J Interv Card Electrophysiol; 2015 Mar; 42(2):69-76. PubMed ID: 25638303 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618 [TBL] [Abstract][Full Text] [Related]
20. Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial. Pisters R; Hohnloser SH; Connolly SJ; Torp-Pedersen C; Naditch-Brûlé L; Page RL; Crijns HJ; Europace; 2014 Feb; 16(2):174-81. PubMed ID: 24072451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]